LL-37, Human

LL-37, Human is a synthetic peptide corresponding to the naturally occurring human cathelicidin antimicrobial peptide LL-37. As a cationic, amphipathic peptide, it plays a crucial role in the innate immune system, exhibiting broad-spectrum antimicrobial activity and participating in various immunomodulatory processes. Its unique structure, characterized by an α-helical conformation, enables interactions with microbial membranes and host cell components, making it a valuable subject in immunology, microbiology, and peptide biochemistry research. The study of LL-37 has significantly advanced our understanding of host defense mechanisms, inflammation, and peptide-based modulation of biological pathways.

Antimicrobial research: LL-37 is widely employed in investigations of host-pathogen interactions and innate immune defense. Its ability to disrupt bacterial, fungal, and viral membranes renders it an important model for studying antimicrobial mechanisms and the development of resistance. Researchers utilize this peptide to elucidate the molecular determinants of membrane permeabilization, assess the efficacy of novel antimicrobial agents, and explore strategies to potentiate endogenous peptide activity against multidrug-resistant pathogens.

Immunomodulation studies: The peptide serves as a key tool for probing the modulation of immune cell function. LL-37 influences chemotaxis, cytokine release, and the activation of various immune cells, including neutrophils, monocytes, and dendritic cells. Experimental systems often incorporate LL-37 to dissect signaling pathways involved in inflammation, immune cell recruitment, and the resolution of infectious or inflammatory insults, providing insight into the regulation of innate and adaptive immune responses.

Peptide structure-function analysis: LL-37 is frequently utilized in structure-activity relationship (SAR) studies aimed at understanding how specific amino acid residues and secondary structures contribute to its biological activity. By synthesizing and testing analogs or fragments of LL-37, researchers can map functional domains responsible for antimicrobial potency, membrane binding, and immunomodulatory effects. Such studies inform the rational design of next-generation peptide therapeutics and biomimetics.

Biofilm inhibition assays: The peptide is a valuable agent for investigating the prevention and disruption of microbial biofilms, which are resilient communities of microorganisms implicated in persistent infections and industrial fouling. LL-37's capacity to penetrate and destabilize biofilm matrices is assessed in vitro using a variety of pathogenic and environmental organisms. These assays help clarify the mechanisms by which host-derived peptides counteract biofilm-associated resistance and support the development of anti-biofilm strategies.

Peptide delivery and formulation research: LL-37 is also explored in the context of peptide delivery systems and formulation science. Researchers examine its stability, cellular uptake, and activity when incorporated into various carriers such as nanoparticles, hydrogels, or liposomes. These studies contribute to optimizing peptide delivery for experimental applications, enhancing bioavailability, and minimizing degradation, which are central challenges in the development of peptide-based research tools and potential therapeutics.

1. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate

2. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

3. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum

4. Quantitative Analysis of Ligands Effects on Bioefficacy of Nanoemulsion encapsulating Depigmenting Active

5. Glucagonlike peptide 2 analogue teduglutide: stimulation of proliferation but reduction of differentiation in human Caco-2 intestinal epithelial cells